CVRX INC (CVRX) Fundamental Analysis & Valuation

NASDAQ:CVRX • US1266381052

Current stock price

7.53 USD
+0.09 (+1.21%)
At close:
7.53 USD
0 (0%)
After Hours:

This CVRX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CVRX Profitability Analysis

1.1 Basic Checks

  • In the past year CVRX has reported negative net income.
  • In the past year CVRX has reported a negative cash flow from operations.
  • In the past 5 years CVRX always reported negative net income.
  • In the past 5 years CVRX always reported negative operating cash flow.
CVRX Yearly Net Income VS EBIT VS OCF VS FCFCVRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M -50M

1.2 Ratios

  • With a Return On Assets value of -50.87%, CVRX is not doing good in the industry: 65.76% of the companies in the same industry are doing better.
  • CVRX has a Return On Equity of -135.56%. This is in the lower half of the industry: CVRX underperforms 69.02% of its industry peers.
Industry RankSector Rank
ROA -50.87%
ROE -135.56%
ROIC N/A
ROA(3y)-43.86%
ROA(5y)-38.6%
ROE(3y)-91.4%
ROE(5y)-68.33%
ROIC(3y)N/A
ROIC(5y)N/A
CVRX Yearly ROA, ROE, ROICCVRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -500 -1K -1.5K

1.3 Margins

  • With an excellent Gross Margin value of 85.33%, CVRX belongs to the best of the industry, outperforming 94.02% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CVRX has grown nicely.
  • CVRX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 85.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.15%
GM growth 5Y2.29%
CVRX Yearly Profit, Operating, Gross MarginsCVRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CVRX Health Analysis

2.1 Basic Checks

  • CVRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CVRX has more shares outstanding
  • The number of shares outstanding for CVRX has been increased compared to 5 years ago.
  • CVRX has a worse debt/assets ratio than last year.
CVRX Yearly Shares OutstandingCVRX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
CVRX Yearly Total Debt VS Total AssetsCVRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of -6.14, we must say that CVRX is in the distress zone and has some risk of bankruptcy.
  • CVRX has a worse Altman-Z score (-6.14) than 73.37% of its industry peers.
  • CVRX has a Debt/Equity ratio of 1.26. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.26, CVRX is doing worse than 77.17% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF N/A
Altman-Z -6.14
ROIC/WACCN/A
WACC10.57%
CVRX Yearly LT Debt VS Equity VS FCFCVRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 7.63 indicates that CVRX has no problem at all paying its short term obligations.
  • CVRX's Current ratio of 7.63 is amongst the best of the industry. CVRX outperforms 88.59% of its industry peers.
  • CVRX has a Quick Ratio of 6.72. This indicates that CVRX is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of CVRX (6.72) is better than 88.59% of its industry peers.
Industry RankSector Rank
Current Ratio 7.63
Quick Ratio 6.72
CVRX Yearly Current Assets VS Current LiabilitesCVRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. CVRX Growth Analysis

3.1 Past

  • CVRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.79%, which is quite impressive.
  • Looking at the last year, CVRX shows a quite strong growth in Revenue. The Revenue has grown by 10.45% in the last year.
  • Measured over the past years, CVRX shows a very strong growth in Revenue. The Revenue has been growing by 56.42% on average per year.
EPS 1Y (TTM)23.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.98%
Revenue 1Y (TTM)10.45%
Revenue growth 3Y36.1%
Revenue growth 5Y56.42%
Sales Q2Q%4.45%

3.2 Future

  • Based on estimates for the next years, CVRX will show a small growth in Earnings Per Share. The EPS will grow by 7.05% on average per year.
  • Based on estimates for the next years, CVRX will show a very strong growth in Revenue. The Revenue will grow by 21.14% on average per year.
EPS Next Y2.19%
EPS Next 2Y6.73%
EPS Next 3Y5.31%
EPS Next 5Y7.05%
Revenue Next Year15.14%
Revenue Next 2Y17.41%
Revenue Next 3Y19.24%
Revenue Next 5Y21.14%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CVRX Yearly Revenue VS EstimatesCVRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M 80M 100M
CVRX Yearly EPS VS EstimatesCVRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 -5 -10 -15 -20

More info and screens

Find the best growth stocksShow best growing peers

0

4. CVRX Valuation Analysis

4.1 Price/Earnings Ratio

  • CVRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CVRX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CVRX Price Earnings VS Forward Price EarningsCVRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CVRX Per share dataCVRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.73%
EPS Next 3Y5.31%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CVRX Dividend Analysis

5.1 Amount

  • CVRX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CVRX Fundamentals: All Metrics, Ratios and Statistics

CVRX INC

NASDAQ:CVRX (3/13/2026, 8:19:04 PM)

After market: 7.53 0 (0%)

7.53

+0.09 (+1.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-12
Earnings (Next)05-06
Inst Owners65.22%
Inst Owner Change7.24%
Ins Owners4.31%
Ins Owner Change11.92%
Market Cap198.11M
Revenue(TTM)56.65M
Net Income(TTM)-53.31M
Analysts80
Price Target12.44 (65.21%)
Short Float %6.32%
Short Ratio3.88
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.72%
Min EPS beat(2)-2.76%
Max EPS beat(2)4.2%
EPS beat(4)2
Avg EPS beat(4)0.7%
Min EPS beat(4)-7.47%
Max EPS beat(4)8.82%
EPS beat(8)2
Avg EPS beat(8)-16.72%
EPS beat(12)6
Avg EPS beat(12)-6.29%
EPS beat(16)10
Avg EPS beat(16)-2.96%
Revenue beat(2)1
Avg Revenue beat(2)0.5%
Min Revenue beat(2)-0.72%
Max Revenue beat(2)1.73%
Revenue beat(4)2
Avg Revenue beat(4)-1.94%
Min Revenue beat(4)-9.51%
Max Revenue beat(4)1.73%
Revenue beat(8)2
Avg Revenue beat(8)-2.23%
Revenue beat(12)5
Avg Revenue beat(12)0.31%
Revenue beat(16)9
Avg Revenue beat(16)1.37%
PT rev (1m)6.09%
PT rev (3m)6.09%
EPS NQ rev (1m)-0.84%
EPS NQ rev (3m)-2.57%
EPS NY rev (1m)-1.69%
EPS NY rev (3m)-0.8%
Revenue NQ rev (1m)-1.47%
Revenue NQ rev (3m)-2.18%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.5
P/FCF N/A
P/OCF N/A
P/B 5.04
P/tB 5.04
EV/EBITDA N/A
EPS(TTM)-2.05
EYN/A
EPS(NY)-2.01
Fwd EYN/A
FCF(TTM)-1.55
FCFYN/A
OCF(TTM)-1.53
OCFYN/A
SpS2.15
BVpS1.49
TBVpS1.49
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -50.87%
ROE -135.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 85.33%
FCFM N/A
ROA(3y)-43.86%
ROA(5y)-38.6%
ROE(3y)-91.4%
ROE(5y)-68.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.15%
GM growth 5Y2.29%
F-Score3
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 76.72%
Cap/Sales 1.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.63
Quick Ratio 6.72
Altman-Z -6.14
F-Score3
WACC10.57%
ROIC/WACCN/A
Cap/Depr(3y)136.6%
Cap/Depr(5y)254.44%
Cap/Sales(3y)1.73%
Cap/Sales(5y)3.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.98%
EPS Next Y2.19%
EPS Next 2Y6.73%
EPS Next 3Y5.31%
EPS Next 5Y7.05%
Revenue 1Y (TTM)10.45%
Revenue growth 3Y36.1%
Revenue growth 5Y56.42%
Sales Q2Q%4.45%
Revenue Next Year15.14%
Revenue Next 2Y17.41%
Revenue Next 3Y19.24%
Revenue Next 5Y21.14%
EBIT growth 1Y13.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year9.88%
EBIT Next 3Y7.85%
EBIT Next 5YN/A
FCF growth 1Y-0.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2.62%
OCF growth 3YN/A
OCF growth 5YN/A

CVRX INC / CVRX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CVRX INC?

ChartMill assigns a fundamental rating of 2 / 10 to CVRX.


What is the valuation status for CVRX stock?

ChartMill assigns a valuation rating of 0 / 10 to CVRX INC (CVRX). This can be considered as Overvalued.


Can you provide the profitability details for CVRX INC?

CVRX INC (CVRX) has a profitability rating of 1 / 10.


Can you provide the financial health for CVRX stock?

The financial health rating of CVRX INC (CVRX) is 3 / 10.